Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05694663 · ClinicalTrials.gov registry record
Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry
A clinical trial of Chronic Ischemic Stroke, sponsored by Icahn School of Medicine at Mount Sinai.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT05694663 is a study of Chronic Ischemic Stroke that is actively recruiting participants, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 40 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05694663, a study of Chronic Ischemic Stroke, is actively recruiting participants, sponsored by Icahn School of Medicine at Mount Sinai.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Vagal Nerve Stimulation is a novel proven therapy for patients with chronic ischemic stroke. The primary objective of this registry is to assess the safety of vagal nerve stimulation for stroke recovery through monitoring the occurrence of serious adverse events associated with the surgical procedure or subsequent paired rehabilitation protocol. This registry will monitor patients undergoing VNS for stroke recovery in the Mount Sinai Health System and collect clinical and procedural details, objective outcomes, and patient-reported outcomes associated with vagal nerve stimulation for stroke recovery.
Conditions Studied
Interventions
- DEVICE Vivistim
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-09 |
| Est. Completion | 2028-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05694663
The ClinicalTrials.gov registry entry for NCT05694663 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chronic Ischemic Stroke appearing as the primary indexed condition, and to 1 intervention - of which Vivistim is the first listed.
NCT05694663 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05694663 about?
NCT05694663 is a clinical study titled "Vagal Nerve Stimulation in Enhanced Stroke Recovery: The VALOR Registry". Vagal Nerve Stimulation is a novel proven therapy for patients with chronic ischemic stroke. The primary objective of this registry is to assess the safety of vagal nerve stimulation for stroke recovery through monitoring the occurrence of serious adverse events associated with the surgical procedur...
What is the current status of trial NCT05694663?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2024-10-09. Estimated completion is 2028-02.
What conditions does trial NCT05694663 study?
This clinical trial studies the following conditions: Chronic Ischemic Stroke.
What interventions are being tested in trial NCT05694663?
The interventions under investigation include: Vivistim (DEVICE).
Who is sponsoring clinical trial NCT05694663?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05694663 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.